Emergent BioSolutions – EBS – Received a multi-year grant from NIAID
Emergent BioSolutions Inc.(NYSE:EBS) announced that it has received a multi-year grant from theNational Institute of Allergy and Infectious Diseases(NIAID), part of theNational Institutes of Health, to advance the development of MVA85A, a candidate vaccine...